한약의 독물동태학적 특성
The Toxicokinetic Characteristics of Korean Traditional Medicines
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Toxicokinetics of Korean Traditional Medicines(TKM) is the description of what rate TKM will enter the body and what happens to it once it is in the body in terms of toxicology. However, it is not easy to understand TKM toxicokinetics because of various factors such as a mixture of 2-30 kinds of herbal materials containing thousands of chemicals, and complex chemical properties. For these reasons, little is known about toxicokinetics of TKM. This study was aimed to characterize and review the absorption,distribution and metabolism of korean traditional medicines in a view of toxicokinetics. For this aim,some of korean traditional medicines were reviewed on a basis of drug-drug interaction, biotransformation and intestinal metabolisms by bacteria. As the factors affecting mainly on toxicokinetics of TKM,individual herbal material’s degree of lipophilicity and metabolic rate, and decoction components according to different kinds of herbal materials were considered. Other factors such as intestinal pH and bacterial activity for metabolism affecting on TKM toxicokinetics, especially in small intestine. It would be a better way for improving the adverse or poor effects caused by TCM if the factors affecting on toxicokinetics of TKM is considered.
Abstract
Toxicokinetics of Korean Traditional Medicines(TKM) is the description of what rate TKM will enter the body and what happens to it once it is in the body in terms of toxicology. However, it is not easy to understand TKM toxicokinetics because of various factors such as a mixture of 2-30 kinds of herbal materials containing thousands of chemicals, and complex chemical properties. For these reasons, little is known about toxicokinetics of TKM. This study was aimed to characterize and review the absorption,distribution and metabolism of korean traditional medicines in a view of toxicokinetics. For this aim,some of korean traditional medicines were reviewed on a basis of drug-drug interaction, biotransformation and intestinal metabolisms by bacteria. As the factors affecting mainly on toxicokinetics of TKM,individual herbal material’s degree of lipophilicity and metabolic rate, and decoction components according to different kinds of herbal materials were considered. Other factors such as intestinal pH and bacterial activity for metabolism affecting on TKM toxicokinetics, especially in small intestine. It would be a better way for improving the adverse or poor effects caused by TCM if the factors affecting on toxicokinetics of TKM is considered.
참고문헌 (35)
- Cheng HM, "Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation", Journal of Ethnopharmacology, 132, pp.429~437 (2010)
- 박영철, "독성학의 분자-생화학적 원리" (2010), 한국학술정보(주)
- Hodgsonm E, "A Textbook of Modern Toxicology" (2010), John Wiley and Sons
- Po HN, "Henderson–Hassel balch Equation : Its History and Limitations", J Chem Educ, 78, pp.1499~1503 (2001)
- de Levie R, "The Henderson–Hasselbalch Equation : Its History and Limitations", J Chem Educ, 80, pp.146~ (2003)
- Colalto C, "Review ; Herbal interactions on absorption of drugs : Mechanisms of action and clinical risk assessment", Pharmacological Research, 62, pp.207~227 (2010)
- Butterweck V, "Potential of pharmacokinetic profiling for detecting herbal interactions with drugs", Clin Pharmacokinet, 47(6), pp.383~397 (2008)
- Zhou W, "Intestinal absorption of forsythoside A in different compositions of Shuang–Huang–Lian", Fitoterapia, 82, pp.375~382 (2011)
- Di B, "Pharmacokinetic comparisons of Shuang–Huang–Lian with the different combinations of its constitutional herbs", J Ethnopharmacol, 107, pp.401~405 (2006)
- Hori Y, "Pharmacognostic studies on ginger and related drugs—part 1 : five sulfonated compounds from Zingiberis rhizome(Shokyo)", Phytochemistry, 62, pp.613~617 (2003)
- Chrubasik S, "Zingiberis rhizoma : A comprehensive review on the ginger effect and efficacy profiles", Phytomedicine, 12, pp.684~701 (2005)
- Dubey AK, "Ginkgo biloba–an appraisal", Kathmandu Univ Med J, 2(3), pp.225~229 (2004)
- Hellum BH, "In vitro inhibition of CYP3A4 metabolism and P-glycoproteinmediated transport by trade herbal products", Basic Clin Pharmacol Toxicol, 102, pp.466~475 (2008)
- Merino G, "Ginseng increases intestinal elimination of albendazole sulfoxide in the rat", Comp Biochem Physiol C, 136, pp.9~15 (2003)
- Gurley BJ, "Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly : St John’s wort, garlic oil, Panax ginseng and Ginkgo biloba", Drugs Aging, 22, pp.525~529 (2005)
- Rajnarayana K, "Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole", Arzneimittelforschung, 54, pp.109~113 (2004)
- Gorski JC, "The effect of echinacea(Echinacea purpurea root) on cytochrome P450 activity in vivo", Clin Pharmacol Ther, 75(1), pp.89~100 (2004)
- Lei HP, "Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in chinese volunteers identified as CYP2C19 poor and estensive metabolizers", Ann Pharmacother, 43, pp.726~731 (2009)
- Marzolini C, "Polymorphisms in human MDR1(Pglycoprotein) : recent advances and clinical relevance", Clin Pharmacol Ther, 75(1), pp.13~23 (2004)
- Lopez-Rodriguez R, "Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers", Pharmacol Res, 58, pp.77~84 (2008)
- 하채림, "장내세균 회복한 후 한약 복용 바람직－약물과 장내세균의 상호관계를 규명하기 위한 약물대사기반연구사업단(단장 김동현)의 연구결과 인용", 연합뉴스, ~ (2010)
- 식품의약품안전평가원, "2010-3-17 보도자료", ~
- Leung K, "Pharmacology of ginsenosides : a literature review", Leung and Wong Chinese Medicine, 5, pp.20~ (2010)
- Zhou S, "Interactions of Herbs with Cytochrome P450", DRUG METABOLISM REVIEWS, 35(1), pp.35~38 (2003)
- Chang TK, "In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1", Drug Metab. Dispos, 30, pp.378~384 (2002)
- Liu Y, "The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity", Biol Pharm Bull, 27(10), pp.1555~1560
- Ling Y, "Metabolism and pharmacokinetics of ginsenosides", Asian Journal of Pharmacodynamics and Pharmacokinetics, 6(2), pp.103~120 (2006)
- Qiana T, "In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3", Journal of chromatography B, 816, pp.223~232 (2005)
- Tawab MA, "Degradation of ginsenosides in humans after oral adninistration", The American Society for Pharmacology and Experimental Therapeutics, 31(8), pp.1065~1071 (2003)
- Heikal OA, "Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots", Biol Pharm Bull, 20(5), pp.517~521 (1997)
- Yong L, "Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics", J Zhejiang Univ Science B, 7(2), pp.99~106 (2006)
- Dietz BM, "Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H : quinone oxidoreductase 1 by alkylating Keap1", Chem Res Toxicol, 21(10), pp.1939~1948 (2008)
- Yu S, "A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma", Phytochemistry, 62, pp.613~617 (2003)
- Ma BL, "Identification of the toxic constituents in Rhizoma Coptidis", Journal of Ethnopharmacology, 128, pp.357~364 (2010)